Chronic Lymphocytic Leukemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Novel agents in CLL: the importance of affordability
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the issue of drug cost in chronic lymphocytic leukemia (CLL). Prof. Montserrat points out that not all patients ... Author: VJHemOnc Added: 07/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2016 Category: Cancer & Oncology Source Type: podcasts

The influence of the European Research Initiative (ERIC) on CLL
Emili Montserrat, MD, PhD from the University of Barcelona, Barcelona, Spain discusses the influence of the European Research Initiative on chronic lymphocytic leukemia CLL (ERIC). Prof. Montserrat me... Author: VJHemOnc Added: 07/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Should we use the word 'cure' in CLL?
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James' University Hospital, Leeds, UK discusses the use of the word 'cure' in chronic lymphocytic leukemia (CLL). According to Prof. Hillmen, the word... Author: VJHemOnc Added: 07/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 25, 2016 Category: Cancer & Oncology Source Type: podcasts

The role of allogeneic stem cell transplantation in CLL
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James' University Hospital, Leeds, UK discusses allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL). According to Prof. Hillme... Author: VJHemOnc Added: 07/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 25, 2016 Category: Cancer & Oncology Source Type: podcasts

How new drugs may change the standard of care for CLL
Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James' University Hospital, Leeds, UK talks about current clinical trials in chronic lymphocytic leukemia (CLL) and how they might change the standard... Author: VJHemOnc Added: 07/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 21, 2016 Category: Cancer & Oncology Source Type: podcasts

A short discussion of the unmet needs of CLL patients
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy discusses the unmet needs of chronic lymphocytic leukemia (CLL) patients. There are issues related the treatment of elderly p... Author: VJHemOnc Added: 07/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2016 Category: Cancer & Oncology Source Type: podcasts

The importance of individually customized treatment for CLL patients
Davide Rossi, MD, PhD from University of Eastern Piedmont, Vercelli, Italy outlines the novel treatment options for chronic lymphocytic leukemia (CLL) patients. Due to the vast number of these new tre... Author: VJHemOnc Added: 07/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2016 Category: Cancer & Oncology Source Type: podcasts

The importance of considering a CLL patient's tumor lysis risk status
Matthew Davids, MD, from Dana-Farber Cancer Institute, Boston, MA outlines the importance of being aware of a patient's tumor lysis risk status in chronic lymphocytic leukemia (CLL). This status can b... Author: VJHemOnc Added: 07/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 11, 2016 Category: Cancer & Oncology Source Type: podcasts

TGR-1202 in CLL and Non-Hodgkin lymphoma
Howard Burris, MD from Sarah Cannon, Nashville, TN discusses TGR-1202 for chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL). TGR-1202 is a PI3K delta inhibitor and Dr Burris discusses ... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Jacqueline Barrientos, MD from Northwell Health, New York, NY discusses drug treatment options for chronic lymphocytic leukemia (CLL), specifically ibrutinib, idelalisib and venetoclax. Current resear... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

How to avoid tumor lysis syndrome when treating CLL patients with venetoclax
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines tumor lysis syndrome as a side-effect of venetoclax in treatment of patients with chronic lymphocytic leukemia (CLL). Tumor ... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

Updates from the CLL14 and CLL2-GiVe trials on CLL
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany outlines current clinical research in chronic lymphocytic leukemia (CLL). Dr Eichhorst discusses the recruitment of patients in the C... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

Lessening the economic burden of treating CLL
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses the economic burden of treating chronic lymphocytic leukemia (CLL). A solution Dr Eichhorst proposes is raising the price o... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

Treating CLL with venetoclax
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses using venetoclax in the treatment of patients with chronic lymphocytic leukemia (CLL). Venetoclax will be approved for high... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts

Updates from current CLL clinical trials
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses updates in current clinical trials being undertaken in the field of chronic lymphocytic leukemia (CLL). Treatment of patien... Author: VJHemOnc Added: 07/05/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2016 Category: Cancer & Oncology Source Type: podcasts